UCDC: Exploring Risk Factors in Asymptomatic Females with Ornithine Transcarbamylase Deficiency
Jun 26, 2024 ·
2m 5s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
New research from the Urea Cycle Disorders Consortium (UCDC). This summary is based on a paper published in the journal Molecular Genetics and Genomic Medicine on April 17, 2024, titled...
show more
New research from the Urea Cycle Disorders Consortium (UCDC). This summary is based on a paper published in the journal Molecular Genetics and Genomic Medicine on April 17, 2024, titled "Are asymptomatic carriers of OTC deficiency always asymptomatic? A multicentric retrospective study of risk using the UCDC longitudinal study database."
Read the paper here: https://onlinelibrary.wiley.com/doi/10.1002/mgg3.2443
Learn more about UCDC: https://ucdc.rarediseasesnetwork.org
Read more about this research from the National Urea Cycle Disorders Foundation: https://nucdf.org/news.html/article/2024/06/28/new-research-shows-female-otc-carriers-heterozygous-females-face-more-symptoms-risks-than-expected
show less
Read the paper here: https://onlinelibrary.wiley.com/doi/10.1002/mgg3.2443
Learn more about UCDC: https://ucdc.rarediseasesnetwork.org
Read more about this research from the National Urea Cycle Disorders Foundation: https://nucdf.org/news.html/article/2024/06/28/new-research-shows-female-otc-carriers-heterozygous-females-face-more-symptoms-risks-than-expected
Information
| Author | RDCRN |
| Organization | RDCRN |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Comments